Literature DB >> 7756105

Chronic tobacco smoking and gender as variables affecting amantadine disposition in healthy subjects.

L T Wong1, D S Sitar, F Y Aoki.   

Abstract

Amantadine HCl (3 mg kg-1) was administered orally to 20 young healthy adults. Its apparent volume of distribution (V2/F) was higher in smokers than nonsmokers, 6.05 +/- 0.86 vs 4.87 +/- 0.85 l kg-1; (mean +/- s.d., 10/group, P < 0.011), and no gender-associated effect was observed. Renal clearance did not vary with time-interval, but urinary recovery at 48 h was higher in men than in women (60.2 +/- 7.5% vs 47.0 +/- 15.0%, P < 0.032). Males had higher renal clearances than females when normalised for body mass index (BMI, 0.492 +/- 0.284 vs 0.248 +/- 0.137 l-1 BMI h-1, (10/group, P < 0.032)). On combining data from a previous study, the weight normalised renal clearance was also higher in men than in women, 0.160 +/- 0.075 vs 0.102 +/- 0.053 l kg-1 h-1 (19/group, P < 0.01). Chronic tobacco smoking did not alter the plasma or renal amantadine clearance. We conclude that gender and tobacco smoking are independent variables effecting amantadine disposition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756105      PMCID: PMC1364986          DOI: 10.1111/j.1365-2125.1995.tb04414.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  A gas chromatographic method for the determination of amantadine in human plasma.

Authors:  P Biandrate; G Tognoni; G Belvedere; A Frigerio; M Rizzo; P L Morselli
Journal:  J Chromatogr       Date:  1972-12-06

2.  Distribution and excretion of 3H-amantadine HCl.

Authors:  M Uchiyama; M Shibuya
Journal:  Chem Pharm Bull (Tokyo)       Date:  1969-04       Impact factor: 1.645

3.  Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine.

Authors:  S E Gaudry; D S Sitar; D D Smyth; J K McKenzie; F Y Aoki
Journal:  Clin Pharmacol Ther       Date:  1993-07       Impact factor: 6.875

Review 4.  Smoking and drug metabolism.

Authors:  G W Dawson; R E Vestal
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

5.  Interference with renal organic cation transport by (-)- and (+)-nicotine at concentrations documented in plasma of habitual tobacco smokers.

Authors:  L T Wong; D D Smyth; D S Sitar
Journal:  J Pharmacol Exp Ther       Date:  1992-04       Impact factor: 4.030

6.  Comparison of pharmacokinetic and safety profiles of amantadine 50- and 100-mg daily doses in elderly nursing home residents.

Authors:  S K Somani; J Degelau; S L Cooper; D R Guay; D Ehresman; D Zaske
Journal:  Pharmacotherapy       Date:  1991       Impact factor: 4.705

Review 7.  Clinical pharmacokinetics of amantadine hydrochloride.

Authors:  F Y Aoki; D S Sitar
Journal:  Clin Pharmacokinet       Date:  1988-01       Impact factor: 6.447

8.  Gender-associated differences in rat renal tubular amantadine transport and absence of stereoselective transport inhibition by quinine and quinidine in distal tubules.

Authors:  L T Wong; M R Escobar; D D Smyth; D S Sitar
Journal:  J Pharmacol Exp Ther       Date:  1993-12       Impact factor: 4.030

  8 in total
  5 in total

1.  Use of antiviral prophylaxis in influenza outbreaks in long term care facilities.

Authors:  A McGeer; D S Sitar; S E Tamblyn; K Faron; P Orr; F Y Aoki
Journal:  Can J Infect Dis       Date:  2000-07

Review 2.  Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease.

Authors:  Michael Murray; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739

Review 3.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

4.  Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3.

Authors:  Jun-ichi Asaka; Tomohiro Terada; Masahiro Okuda; Toshiya Katsura; Ken-ichi Inui
Journal:  Pharm Res       Date:  2006-03-25       Impact factor: 4.200

Review 5.  Gender differences in kidney function.

Authors:  Ivan Sabolić; Abdul R Asif; Wolfgang E Budach; Christoph Wanke; Andrew Bahn; Gerhard Burckhardt
Journal:  Pflugers Arch       Date:  2007-07-19       Impact factor: 3.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.